During Matthew 13D and 13G filings for Ovid Therapeutics Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-02-14 5:29 pm Sale | 2021-12-31 | 13G | Ovid Therapeutics Inc. OVID | During Matthew | 3,103,932 4.500% | -916,862 (-22.80%) | Filing |
| 2021-02-16 4:39 pm Sale | 2020-12-31 | 13G | Ovid Therapeutics Inc. OVID | During Matthew | 4,020,794 6.300% | -964,811 (-19.35%) | Filing |